VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Thursday, January 8, 2026
Stock Comparison
Adyen N.V. vs Boston Scientific Corporation
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Adyen N.V.
ADYEN · Euronext Amsterdam
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Adyen N.V.'s moat claims, evidence, and risks.
View ADYEN analysisBoston Scientific Corporation
BSX · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Boston Scientific Corporation's moat claims, evidence, and risks.
View BSX analysisComparison highlights
- Moat score gap: Boston Scientific Corporation leads (65 / 100 vs 63 / 100 for Adyen N.V.).
- Segment focus: Adyen N.V. has 3 segments (58.4% in Digital); Boston Scientific Corporation has 5 segments (49.8% in Cardiology).
- Moat breadth: Adyen N.V. has 6 moat types across 4 domains; Boston Scientific Corporation has 6 across 3.
Primary market context
Adyen N.V.
Digital
Enterprise payment processing and acquiring for online/digital commerce
Global
Enterprise merchants and digital-native businesses
PSP / gateway + processor + (direct or indirect) acquiring enablement
58.4%
Boston Scientific Corporation
Cardiology
Cardiology devices (interventional cardiology, structural heart, electrophysiology, cardiac rhythm management and remote monitoring)
Global
Hospitals/cath labs/EP labs and specialty clinics (cardiologists, electrophysiologists)
Medical device OEM / implantables + procedure devices + service-enabled monitoring
49.8%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Adyen N.V. strengths
Boston Scientific Corporation strengths
Segment mix
Adyen N.V. segments
Full profile >Digital
Oligopoly
Unified Commerce
Competitive
Platforms
Oligopoly
Boston Scientific Corporation segments
Full profile >Endoscopy
Oligopoly
Urology
Competitive
Neuromodulation
Oligopoly
Cardiology
Oligopoly
Peripheral Interventions
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.